Delving into the Latest Updates on Strekin AG with Synapse

概览

关联

2

项与 Strekin AG 相关的临床试验

NCT03331627 / Completed临床3期

A Phase III Multicenter, Double-blind, Placebo-controlled, Study Evaluating the Safety, and Efficacy of STR001 Treatment in Adults With Sudden Sensorineural Hearing Loss

a multicenter, double-blind, placebo-controlled study in patients with Sudden Sensorineural Hearing Loss (SSHL). Patients will be treated with STR001 thermogel (STR001-IT) / STR001 tablets (STR001-ER) and corresponding Placebo on top of standard of care.

开始日期2018-02-24

申办/合作机构

Strekin AG初创企业

EUCTR2015-002672-25-DE / Not yet recruiting临床2期

A Phase II multicenter, placebo-controlled, proof-of-concept study evaluating the safety, and efficacy of intratympanic STR001 thermogel to preserve residual hearing in adults undergoing cochlear implant surgery

开始日期2015-11-18

申办/合作机构

Strekin AG初创企业

100 项与 Strekin AG 相关的临床结果

登录后查看更多信息

0 项与 Strekin AG 相关的专利（医药）

登录后查看更多信息

100 项与 Strekin AG 相关的药物交易

登录后查看更多信息

100 项与 Strekin AG 相关的转化医学

登录后查看更多信息